IMEXPHARM CORPORATIONIMEXPHARM CORPORATIONIMEXPHARM CORPORATION

IMEXPHARM CORPORATION

No trades
See on Supercharts

IMP fundamentals

IMEXPHARM CORPORATION key financial stats and ratios

IMP price-to-sales ratio is 3.21. The company has an Enterprise Value to EBITDA ratio of 14.63. As of 2023 they employed 1.42 k people.

Statistics
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
Price to earnings ratio
Price to cash flow ratio
Currency: VND
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Current
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios